These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 27357212)

  • 21. Cerebrospinal fluid α-synuclein and Lewy body-like symptoms in normal controls, mild cognitive impairment, and Alzheimer's disease.
    Mackin RS; Insel P; Zhang J; Mohlenhoff B; Galasko D; Weiner M; Mattsson N
    J Alzheimers Dis; 2015; 43(3):1007-16. PubMed ID: 25125463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of Lewy pathology in the visual pathway of brains of dementia with Lewy bodies.
    Yamamoto R; Iseki E; Murayama N; Minegishi M; Marui W; Togo T; Katsuse O; Kato M; Iwatsubo T; Kosaka K; Arai H
    J Neurol Sci; 2006 Jul; 246(1-2):95-101. PubMed ID: 16624323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebral metabolic dysfunction in patients with dementia with Lewy bodies and visual hallucinations.
    Perneczky R; Drzezga A; Boecker H; Förstl H; Kurz A; Häussermann P
    Dement Geriatr Cogn Disord; 2008; 25(6):531-8. PubMed ID: 18477846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dementia with Lewy bodies showing advanced Lewy pathology but minimal Alzheimer pathology--Lewy pathology causes neuronal loss inducing progressive dementia.
    Uchikado H; Iseki E; Tsuchiya K; Togo T; Katsuse O; Uéda K; Kato M; Kosaka K
    Clin Neuropathol; 2002; 21(6):269-77. PubMed ID: 12489676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dementia with Lewy bodies: association of Alzheimer pathology with functional connectivity networks.
    Schumacher J; Gunter JL; Przybelski SA; Jones DT; Graff-Radford J; Savica R; Schwarz CG; Senjem ML; Jack CR; Lowe VJ; Knopman DS; Fields JA; Kremers WK; Petersen RC; Graff-Radford NR; Ferman TJ; Boeve BF; Thomas AJ; Taylor JP; Kantarci K
    Brain; 2021 Nov; 144(10):3212-3225. PubMed ID: 34114602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies.
    Higuchi M; Tashiro M; Arai H; Okamura N; Hara S; Higuchi S; Itoh M; Shin RW; Trojanowski JQ; Sasaki H
    Exp Neurol; 2000 Apr; 162(2):247-56. PubMed ID: 10739631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies.
    Deramecourt V; Bombois S; Maurage CA; Ghestem A; Drobecq H; Vanmechelen E; Lebert F; Pasquier F; Delacourte A
    J Neuropathol Exp Neurol; 2006 Mar; 65(3):278-88. PubMed ID: 16651889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in CD200 and intercellular adhesion molecule-1 (ICAM-1) levels in brains of Lewy body disorder cases are associated with amounts of Alzheimer's pathology not α-synuclein pathology.
    Walker DG; Lue LF; Tang TM; Adler CH; Caviness JN; Sabbagh MN; Serrano GE; Sue LI; Beach TG
    Neurobiol Aging; 2017 Jun; 54():175-186. PubMed ID: 28390825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The brain metabolic signature of visual hallucinations in dementia with Lewy bodies.
    Iaccarino L; Sala A; Caminiti SP; Santangelo R; Iannaccone S; Magnani G; Perani D
    Cortex; 2018 Nov; 108():13-24. PubMed ID: 30098477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural alteration of the dorsal visual network in DLB patients with visual hallucinations: a cortical thickness MRI study.
    Delli Pizzi S; Franciotti R; Tartaro A; Caulo M; Thomas A; Onofrj M; Bonanni L
    PLoS One; 2014; 9(1):e86624. PubMed ID: 24466177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accumulation of α-synuclein in dementia with Lewy bodies is associated with decline in the α-synuclein-degrading enzymes kallikrein-6 and calpain-1.
    Miners JS; Renfrew R; Swirski M; Love S
    Acta Neuropathol Commun; 2014 Dec; 2():164. PubMed ID: 25476568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes to the lateral geniculate nucleus in Alzheimer's disease but not dementia with Lewy bodies.
    Erskine D; Taylor JP; Firbank MJ; Patterson L; Onofrj M; O'Brien JT; McKeith IG; Attems J; Thomas AJ; Morris CM; Khundakar AA
    Neuropathol Appl Neurobiol; 2016 Jun; 42(4):366-76. PubMed ID: 25967384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathology and temporal onset of visual hallucinations, misperceptions and family misidentification distinguishes dementia with Lewy bodies from Alzheimer's disease.
    Ferman TJ; Arvanitakis Z; Fujishiro H; Duara R; Parfitt F; Purdy M; Waters C; Barker W; Graff-Radford NR; Dickson DW
    Parkinsonism Relat Disord; 2013 Feb; 19(2):227-31. PubMed ID: 23182311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relevance of subcortical visual pathways disruption to visual symptoms in dementia with Lewy bodies.
    Delli Pizzi S; Maruotti V; Taylor JP; Franciotti R; Caulo M; Tartaro A; Thomas A; Onofrj M; Bonanni L
    Cortex; 2014 Oct; 59():12-21. PubMed ID: 25113955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The limbic and neocortical contribution of α-synuclein, tau, and amyloid β to disease duration in dementia with Lewy bodies.
    Ferman TJ; Aoki N; Crook JE; Murray ME; Graff-Radford NR; van Gerpen JA; Uitti RJ; Wszolek ZK; Graff-Radford J; Pedraza O; Kantarci K; Boeve BF; Dickson DW
    Alzheimers Dement; 2018 Mar; 14(3):330-339. PubMed ID: 29100980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.
    Sierra M; Gelpi E; Martí MJ; Compta Y
    Neuropathol Appl Neurobiol; 2016 Aug; 42(5):451-62. PubMed ID: 26810462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lewy body pathology in Alzheimer's disease.
    Kotzbauer PT; Trojanowsk JQ; Lee VM
    J Mol Neurosci; 2001 Oct; 17(2):225-32. PubMed ID: 11816795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subtypes of dementia with Lewy bodies are associated with α-synuclein and tau distribution.
    Ferman TJ; Aoki N; Boeve BF; Aakre JA; Kantarci K; Graff-Radford J; Parisi JE; Van Gerpen JA; Graff-Radford NR; Uitti RJ; Pedraza O; Murray ME; Wszolek ZK; Reichard RR; Fields JA; Ross OA; Knopman DS; Petersen RC; Dickson DW
    Neurology; 2020 Jul; 95(2):e155-e165. PubMed ID: 32561678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lewy body variant of Alzheimer's disease or cerebral type lewy body disease? Two autopsy cases of presenile onset with minimal involvement of the brainstem.
    Yokota O; Tsuchiya K; Uchihara T; Ujike H; Terada S; Takahashi M; Kimura Y; Ishizu H; Akiyama H; Kuroda S
    Neuropathology; 2007 Feb; 27(1):21-35. PubMed ID: 17319280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies.
    Colom-Cadena M; Gelpi E; Charif S; Belbin O; Blesa R; Martí MJ; Clarimón J; Lleó A
    J Neuropathol Exp Neurol; 2013 Dec; 72(12):1203-12. PubMed ID: 24226269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.